Platelet-activating factor and analogues: comparative studies with human neutrophils and rabbit platelets

Area of Science:

• Immunology
• Biochemistry
• Cell Biology

Background:

• Platelet-activating factor (PAF) is a potent lipid mediator involved in inflammation and thrombosis.
• Neutrophils and platelets are key immune cells that play critical roles in inflammatory responses.

Purpose of the Study:

• To investigate the structure-activity relationships of PAF analogues in platelet and neutrophil activation.
• To elucidate the mechanism of neutrophil activation by PAF and its analogues.

Main Methods:

• Stimulation of rabbit platelets and human neutrophils with PAF and 12 structural analogues.
• Measurement of platelet aggregation and serotonin release.
• Assessment of neutrophil aggregation, degranulation, and deoxyglucose uptake.
• Evaluation of selective desensitization of neutrophils to PAF, C5a, and formylated oligopeptide.

Main Results:

• PAF and analogues induced platelet and neutrophil aggregation, serotonin release, and degranulation.
• Potencies of analogues varied significantly but correlated highly across all assays (r >= 0.93).
• Analogues selectively desensitized neutrophils to PAF but not to C5a or formylated oligopeptide, indicating a common activation pathway.

Conclusions:

• Structure-activity relationships for PAF analogues are similar for both platelet and neutrophil functions.
• Neutrophil activation by PAF and its analogues likely occurs through a common, stereospecific receptor mechanism.
• These findings support the existence of similar PAF receptors on neutrophils and platelets with comparable structural specificities.